N-terminal-pro-brain natriuretic peptide is decreased in insulin dependent gestational diabetes mellitus: A prospective cohort trial

Cardiovascular Diabetology

Volumn 10, Issue , 2011, Pages

  Andreas, Martin ^a   Zeisler, Harald ^b   Handisurya, Ammon ^a   Franz, Maximilian B ^b   Gottsauner Wolf, Michael ^a   Wolzt, Michael ^a   Kautzky Willer, Alexandra ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIV KLIN FÜR FRAUENHEILKUNDE   (Austria)

Author keywords

GDM; Preeclampsia; PregnancyNT proBNP

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; INSULIN; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO BRAIN NATRIURETIC PEPTIDE (1 76); PRO-BRAIN NATRIURETIC PEPTIDE (1-76); PROTEIN PRECURSOR;

ARTICLE; BODY MASS; CONTROLLED STUDY; DIET THERAPY; DISEASE SEVERITY; FEMALE; GESTATIONAL AGE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; OUTPATIENT CARE; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; BLOOD; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; METABOLISM; PREGNANCY; PREGNANCY COMPLICATION; PROSPECTIVE STUDY; REFERENCE VALUE;

BIOLOGICAL MARKERS; BODY MASS INDEX; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES, GESTATIONAL; FEMALE; HUMANS; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; REFERENCE VALUES;

EID: 79953853415     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-10-28     Document Type: Article

References (22)

1. Yasuhi I, Hogan JW, Canick J, Sosa MB, Carpenter MW. Midpregnancy serum C-peptide concentration and subsequent pregnancy-induced hypertension. Diabetes Care 2001, 24(4):743-747. 10.2337/diacare.24.4.743, 11315841.
2. Wolf M, Sandler L, Munoz K, Hsu K, Ecker JL, Thadhani R. First trimester insulin resistance and subsequent preeclampsia: a prospective study. J Clin Endocrinol Metab 2002, 87(4):1563-1568. 10.1210/jc.87.4.1563, 11932283.
3. Sermer M, Naylor CD, Gare DJ, Kenshole AB, Ritchie JW, Farine D, Cohen HR, McArthur K, Holzapfel S, Biringer A, et al. Impact of increasing carbohydrate intolerance on maternal-fetal outcomes in 3637 women without gestational diabetes. The Toronto Tri-Hospital Gestational Diabetes Project. Am J Obstet Gynecol 1995, 173(1):146-156. 10.1016/0002-9378(95)90183-3, 7631672.
4. Tihtonen KM, Koobi T, Vuolteenaho O, Huhtala HS, Uotila JT. Natriuretic peptides and hemodynamics in preeclampsia. Am J Obstet Gynecol 2007, 196(4):328. e321-327, 10.1016/j.ajog.2006.11.033, 17403408.
5. Mukoyama M, Nakao K, Hosoda K, Suga S, Saito Y, Ogawa Y, Shirakami G, Jougasaki M, Obata K, Yasue H, et al. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 1991, 87(4):1402-1412. 10.1172/JCI115146, 295184, 1849149.
6. Yasue H, Yoshimura M, Sumida H, Kikuta K, Kugiyama K, Jougasaki M, Ogawa H, Okumura K, Mukoyama M, Nakao K. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994, 90(1):195-203.
7. Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med 1998, 339(5):321-328. 10.1056/NEJM199807303390507, 9682046.
8. Hall C. Essential biochemistry and physiology of (NT-pro)BNP. Eur J Heart Fail 2004, 6(3):257-260. 10.1016/j.ejheart.2003.12.015, 14987573.
9. Mueller C, Breidthardt T, Laule-Kilian K, Christ M, Perruchoud AP. The integration of BNP and NT-proBNP into clinical medicine. Swiss Med Wkly 2007, 137(1-2):4-12.
10. Hadar E, Hod M. Establishing consensus criteria for the diagnosis of diabetes in pregnancy following the HAPO study. Ann N Y Acad Sci 1205:88-93. 10.1111/j.1749-6632.2010.05671.x, 20840258.
11. Magnusson M, Melander O, Israelsson B, Grubb A, Groop L, Jovinge S. Elevated plasma levels of Nt-proBNP in patients with type 2 diabetes without overt cardiovascular disease. Diabetes Care 2004, 27(8):1929-1935. 10.2337/diacare.27.8.1929, 15277419.
12. Raymond I, Groenning BA, Hildebrandt PR, Nilsson JC, Baumann M, Trawinski J, Pedersen F. The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population. Heart 2003, 89(7):745-751. 10.1136/heart.89.7.745, 1767734, 12807847.
13. Magnusson M, Jovinge S, Shahgaldi K, Israelsson B, Groop L, Melander O. Brain natriuretic peptide is related to diastolic dysfunction whereas urinary albumin excretion rate is related to left ventricular mass in asymptomatic type 2 diabetes patients. Cardiovasc Diabetol 9:2. 10.1186/1475-2840-9-2, 2817679, 20078898.
14. Tildesley HD, Aydin CM, Ignaszewski A, Strelzow JA, Yu E, Bondy G. Sulfonylurea therapy is associated with increased NT-proBNP levels in the treatment of type 2 diabetes. Int J Cardiol 2007, 115(3):312-317. 10.1016/j.ijcard.2006.03.014, 16824633.
15. Bosio PM, McKenna PJ, Conroy R, O'Herlihy C. Maternal central hemodynamics in hypertensive disorders of pregnancy. Obstet Gynecol 1999, 94(6):978-984. 10.1016/S0029-7844(99)00430-5, 10576186.
16. Franz MB, Andreas M, Schiessl B, Zeisler H, Neubauer A, Kastl SP, Hess G, Rhomberg F, Zdunek D, Maurer G, et al. NT-proBNP is increased in healthy pregnancies compared to non-pregnant controls. Acta Obstet Gynecol Scand 2009, 88(2):234-237. 10.1080/00016340802596025, 19096946.
17. Oren S, Golzman B, Reitblatt T, Turkot S, Kogan J, Segal S. Gestational diabetes mellitus and hypertension in pregnancy: hemodynamics and diurnal arterial pressure profile. J Hum Hypertens 1996, 10(8):505-509.
18. Seong WJ, Kim SC, Hong DG, Koo TB, Park IS. Amino-Terminal Pro-Brain Natriuretic Peptide Levels in Hypertensive Disorders Complicating Pregnancy. Hypertens Pregnancy
19. Tanous D, Siu SC, Mason J, Greutmann M, Wald RM, Parker JD, Sermer M, Colman JM, Silversides CK. B-type natriuretic peptide in pregnant women with heart disease. J Am Coll Cardiol 56(15):1247-1253. 10.1016/j.jacc.2010.02.076, 20883932.
20. Bayes-Genis A, DeFilippi C, Januzzi JL. Understanding amino-terminal pro-B-type natriuretic peptide in obesity. Am J Cardiol 2008, 101(3A):89-94. 10.1016/j.amjcard.2007.11.030, 18243866.
21. Muscari A, Berzigotti A, Bianchi G, Giannoni C, Ligabue A, Magalotti D, Sbano D, Zacchini A, Zoli M. Non-cardiac determinants of NT-proBNP levels in the elderly: relevance of haematocrit and hepatic steatosis. Eur J Heart Fail 2006, 8(5):468-476. 10.1016/j.ejheart.2005.10.018, 16386463.
22. Johnston N, Jernberg T, Lindahl B, Lindback J, Stridsberg M, Larsson A, Venge P, Wallentin L. Biochemical indicators of cardiac and renal function in a healthy elderly population. Clin Biochem 2004, 37(3):210-216. 10.1016/j.clinbiochem.2003.11.002, 14972643.